推薦產品
蒸汽壓力
<0.01 mmHg ( 20 °C)
1 mmHg ( 795 °C)
產品線
ReagentPlus®
化驗
≥99.0%
形狀
powder
pH值
5-6 (25 °C, 119 g/L)
mp
734 °C (lit.)
SMILES 字串
[K+].[Br-]
InChI
1S/BrH.K/h1H;/q;+1/p-1
InChI 密鑰
IOLCXVTUBQKXJR-UHFFFAOYSA-M
尋找類似的產品？ 前往 產品比較指南
應用
可用于除去外周膜蛋白。
法律資訊
ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
Redi-Dri is a trademark of Sigma-Aldrich Co. LLC
訊號詞
Warning
危險聲明
危險分類
Eye Irrit. 2
儲存類別代碼
13 - Non Combustible Solids
水污染物質分類（WGK）
WGK 1
閃點（°F）
Not applicable
閃點（°C）
Not applicable
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。
客戶也查看了
Jun Pan et al.
Organic letters, 13(18), 4974-4976 (2011-08-26)
A facile Pd-catalyzed conversion of aryl and vinyl triflates to aryl and vinyl halides (bromides and chlorides) is described. This method allows convenient access to a variety of aryl, heteroaryl, and vinyl halides in good to excellent yields and with
Kazue Kurihara
Advances in colloid and interface science, 158(1-2), 130-138 (2010-05-11)
Brush layers of polyelectrolytes, ionized chains of poly(glutamic acid) (PLGA) and poly(lysine) (PLL), prepared by the Langmuir-Blodgett method, were characterized using the surface forces measurements at various pHs, salt concentrations and chain densities. This paper reviews the major results: (1)
Keiichiro Hayashi et al.
Epilepsia, 52(5), 1010-1017 (2011-04-13)
Mutations in the SCN1A gene, which encodes the α1 subunit of voltage-gated sodium channels, cause generalized epilepsy with febrile seizures plus (GEFS+) and severe myoclonic epilepsy of infancy (SMEI). N1417H-Scn1a mutant rats are considered to be an animal model of
Pascal Miéville et al.
Magnetic resonance in chemistry : MRC, 49(11), 689-692 (2011-10-18)
As previously demonstrated by Thurber and Tycko, the peak position of (79)Br in potassium bromide (KBr) allows one to determine the temperature of a spinning sample. We propose to adapt the original design by using a compact KBr tablet placed
Hitesh Kulhari et al.
Nanomedicine : nanotechnology, biology, and medicine, 11(6), 1511-1520 (2015-05-03)
Docetaxel (DTX) is an anticancer drug that is used alone and in combination with other drugs to treat tumours. However, it suffers from the drawback of non-specific cytotoxicity. To improve the therapeutic potential of DTX, we report the synthesis of
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務